InforMax Appoints James Bernstein as President | GenomeWeb

NEW YORK, Dec 19 – InforMax has promoted James Bernstein, formerly chief operating officer and executive vice president of strategic development, to the position of president, the company announced Tuesday.

Bernstein will report to Alex Titomirov, InforMax’s founder, CEO, and chairman, the company said. Titomirov formerly held the title of president.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.